Carole Bye

960 total citations
29 papers, 752 citations indexed

About

Carole Bye is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Carole Bye has authored 29 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Carole Bye's work include Pharmaceutical studies and practices (5 papers), Respiratory and Cough-Related Research (4 papers) and Olfactory and Sensory Function Studies (4 papers). Carole Bye is often cited by papers focused on Pharmaceutical studies and practices (5 papers), Respiratory and Cough-Related Research (4 papers) and Olfactory and Sensory Function Studies (4 papers). Carole Bye collaborates with scholars based in United Kingdom, United States and South Africa. Carole Bye's co-authors include A. W. Peck, A. S. E. Fowle, D. T. D. Hughes, D W Empey, A. D. Munro‐Faure, John O’Grady, L. A. Laitinen, AW Peck, Donald A. Dewsbury and Gerald A. Young and has published in prestigious journals such as Nature, The Lancet and Psychopharmacology.

In The Last Decade

Carole Bye

29 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carole Bye United Kingdom 16 150 136 109 88 86 29 752
Miguel A. Zinny United States 15 122 0.8× 80 0.6× 91 0.8× 66 0.8× 88 1.0× 28 666
Richard A. Okerholm United States 18 170 1.1× 109 0.8× 45 0.4× 131 1.5× 87 1.0× 36 842
SJ Warrington United Kingdom 19 285 1.9× 104 0.8× 57 0.5× 229 2.6× 54 0.6× 53 940
Francis Gengo United States 14 153 1.0× 76 0.6× 42 0.4× 75 0.9× 49 0.6× 36 659
Menger Chung United States 17 262 1.7× 63 0.5× 43 0.4× 119 1.4× 102 1.2× 29 891
Per T. Thyrum United States 14 130 0.9× 109 0.8× 76 0.7× 96 1.1× 98 1.1× 30 714
Jürgen H. Hengstmann Germany 15 159 1.1× 89 0.7× 50 0.5× 56 0.6× 54 0.6× 35 743
G. Bianchetti France 21 277 1.8× 111 0.8× 61 0.6× 248 2.8× 231 2.7× 78 1.5k
Ram P. Kapil United States 14 71 0.5× 145 1.1× 35 0.3× 114 1.3× 60 0.7× 46 731
C.J. van Boxtel Netherlands 20 84 0.6× 92 0.7× 50 0.5× 69 0.8× 96 1.1× 47 893

Countries citing papers authored by Carole Bye

Since Specialization
Citations

This map shows the geographic impact of Carole Bye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Bye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Bye more than expected).

Fields of papers citing papers by Carole Bye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Bye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Bye. The network helps show where Carole Bye may publish in the future.

Co-authorship network of co-authors of Carole Bye

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Bye. A scholar is included among the top collaborators of Carole Bye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Bye. Carole Bye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Katy H. P., Philip T. Leese, Scott McNeal, et al.. (2002). The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers. Clinical Therapeutics. 24(4). 583–594. 15 indexed citations
2.
Falcoz, Christine, J.M. Jenkins, Carole Bye, et al.. (2002). Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 42(8). 887–898. 42 indexed citations
3.
Moore, Katy H. P., et al.. (2002). The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers. Clinical Therapeutics. 24(11). 1887–1901. 7 indexed citations
4.
Johnson, Mark, J.M. Jenkins, & Carole Bye. (2000). A study of the pharmacokinetic interaction between lamivudine and alpha interferon. European Journal of Clinical Pharmacology. 56(4). 289–292. 5 indexed citations
5.
Hamilton, M. J., et al.. (1982). A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man.. British Journal of Clinical Pharmacology. 13(3). 441–444. 15 indexed citations
6.
Bye, Carole, J. Cooper, D W Empey, et al.. (1980). Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold.. BMJ. 281(6234). 189–190. 34 indexed citations
8.
Empey, D W, L. A. Laitinen, Gerald A. Young, Carole Bye, & D. T. D. Hughes. (1979). Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjects. European Journal of Clinical Pharmacology. 16(6). 393–397. 61 indexed citations
9.
O’Grady, John, et al.. (1978). Effect of a standard breakfast on digoxin absorption in normal subjects. Clinical Pharmacology & Therapeutics. 23(3). 315–319. 24 indexed citations
10.
O’Grady, John, et al.. (1978). The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol. European Journal of Clinical Pharmacology. 14(5). 357–360. 4 indexed citations
11.
Bye, Carole, et al.. (1978). Drowsiness, impaired performance and tricyclic antidepressants drugs.. British Journal of Clinical Pharmacology. 6(2). 155–162. 31 indexed citations
12.
O’Grady, John, et al.. (1978). The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.. British Journal of Clinical Pharmacology. 5(5). 465–467. 27 indexed citations
13.
Peck, A. W., et al.. (1976). Residual effects of hypnotic drugs: Evidence for individual differences on vigilance. Psychopharmacology. 47(2). 213–216. 12 indexed citations
14.
Johnson, Brian F. G., I. K. Smith, J T LaBrooy, & Carole Bye. (1976). The Nature of the β-Adrenoreceptor Controlling Plasma Renin Activity in Man. Clinical Science. 51(s3). 113s–115s. 8 indexed citations
15.
Bye, Carole, et al.. (1975). Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.. Heart. 37(2). 203–208. 31 indexed citations
16.
Peck, A. W., A. S. E. Fowle, & Carole Bye. (1975). A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: Implications for the mechanism of drug induced drowsiness. European Journal of Clinical Pharmacology. 8(6). 455–463. 49 indexed citations
17.
Bye, Carole, Donald A. Dewsbury, & A. W. Peck. (1974). EFFECTS ON THE HUMAN CENTRAL NERVOUS SYSTEM OF TWO ISOMERS OF EPHEDRINE AND TRIPROLIDINE, AND THEIR INTERACTION. British Journal of Clinical Pharmacology. 1(1). 71–78. 43 indexed citations
18.
Johnson, Brian F. G., et al.. (1974). The Relation of Antihypertensive Treatment to Plasma Lipids and other Vascular Risk Factors in Hypertensives. Clinical Science. 47(2). 9P–10P. 19 indexed citations
19.
Bye, Carole, et al.. (1974). Lack of effect of Avena sativa on cigarette smoking. Nature. 252(5484). 580–581. 6 indexed citations
20.
Bye, Carole, et al.. (1973). RATE OF DISSOLUTION OF DIGOXIN TABLETS AS A PREDICTOR OF ABSORPTION. The Lancet. 301(7818). 1473–1475. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026